Publication:
An Evaluation of Hepatitis E Virus Molecular Typing Methods

dc.contributor.authorBaylis, Sally A
dc.contributor.authorAdlhoch, Cornelia
dc.contributor.authorChilds, Liam
dc.contributor.authorHEV Sequencing Study Group
dc.contributor.authorAvellón, Ana
dc.contributor.funderUnión Europea. European Centre for Disease Prevention and Control (ECDC)es_ES
dc.contributor.funderFederal Ministry for Health (Alemania)es_ES
dc.contributor.funderMinistero della Salute (Italia)es_ES
dc.contributor.funderDutch Food and Consumer Safety Authorityes_ES
dc.contributor.funderMinisterio de Ciencia e Innovación (España)es_ES
dc.contributor.funderHealth Canadaes_ES
dc.contributor.funderAbbottes_ES
dc.date.accessioned2023-05-09T09:54:31Z
dc.date.available2023-05-09T09:54:31Z
dc.date.issued2022
dc.description.abstractBackground: Hepatitis E virus (HEV) is a major cause of acute viral hepatitis. Better understanding of HEV subtypes involved in hepatitis E infections is essential. Investigation of sources and routes of transmission and the identification of potential clusters/outbreaks rely upon molecular typing of viral strains. A study was carried out to evaluate the ability of laboratories to undertake molecular typing with genotype and subtype determination. Methods: A blinded panel of 11 different Orthohepevirus A strains was distributed to 28 laboratories performing HEV sequence analysis. Laboratories used their routine HEV sequencing and genotyping methods. Results: Results were returned by 25 laboratories. Overall, 93% samples were assigned to the correct genotype and 81% were assigned to the correct subtype. Fragments amplified for typing ranged in size and the sequencing assays targeted both the structural and non-structural protein-coding regions. There was good agreement between the reported sequences where methods targeted overlapping fragments. In some cases, incorrect genotypes/subtypes were reported, including those not contained in the panel, and in one case, a genotype was reported for a blinded control sample containing Zika virus; collectively these data indicate contamination problems. Conclusions: In general, identification of genotypes was good; however, in a small number of cases, there was a failure to generate sequences from some of the samples. There was generally broad agreement between the use of online typing tools such as the one provided by HEVnet and curated lists of published HEV reference sequences; however, going forward harmonization between these resources is essential.es_ES
dc.description.peerreviewedes_ES
dc.description.sponsorshipThis work was supported by a service contract ECD.9621 from European Centre for Disease Prevention and Control. N. Nasheri and J. Harlow, Health Canada internal funds: Internal funding was used to perform viral detection and genotyping. K. Schilling-Loeffler, R. Johne, and V.M. Corman, grant of the German Federal Ministry of Health with regard to a decision of the German Bundestag by the Federal Government (CHED project grant no. ZMVI1-2518FSB705) to institution; G. La Rosa and E. Suffredini, Italian Ministry of Health; I.L.A. Boxman, R.A.M. Dirks, Dutch Food and Consumer Safety Authority; B. Hogema, Sanquin; A. Avellon, Diasorin Iberica, Abbott; G. Sanchez and E.C. Ferrando, MICIU project AGL2017-82909. The study was funded by ECDC with PEI receiving these funds to cover sample preparation, pre-testing and transport costs.es_ES
dc.format.number1es_ES
dc.format.page181-191es_ES
dc.format.volume68es_ES
dc.identifier.citationClin Chem. 2022;68(1):181-191.es_ES
dc.identifier.doi10.1093/clinchem/hvab186es_ES
dc.identifier.e-issn1530-8561es_ES
dc.identifier.journalClinical chemistryes_ES
dc.identifier.pubmedID34969109es_ES
dc.identifier.urihttp://hdl.handle.net/20.500.12105/16030
dc.language.isoenges_ES
dc.publisherOxford University Presses_ES
dc.relation.projectFECYTinfo:eu-repo/grantAgreement/ES/AGL2017-82909es_ES
dc.relation.publisherversionhttps://doi.org/10.1093/clinchem/hvab186es_ES
dc.repisalud.centroISCIII::Centro Nacional de Microbiologíaes_ES
dc.repisalud.institucionISCIIIes_ES
dc.rights.accessRightsopen accesses_ES
dc.rights.licenseAttribution-NonCommercial-NoDerivatives 4.0 Internacional*
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/*
dc.subjectHEVes_ES
dc.subjectGenotypeses_ES
dc.subjectHepatitis E viruses_ES
dc.subjectSequencinges_ES
dc.subjectSubtypees_ES
dc.subject.meshHepatitis Ees_ES
dc.subject.meshHepatitis E viruses_ES
dc.subject.meshZika Viruses_ES
dc.subject.meshZika Virus Infectiones_ES
dc.subject.meshGenotypees_ES
dc.subject.meshHumanses_ES
dc.subject.meshMolecular Typinges_ES
dc.subject.meshPhylogenyes_ES
dc.subject.meshRNA, Virales_ES
dc.titleAn Evaluation of Hepatitis E Virus Molecular Typing Methodses_ES
dc.typejournal articlees_ES
dc.type.hasVersionVoRes_ES
dspace.entity.typePublication
relation.isAuthorOfPublication392ba1dd-467b-4d9e-a8f5-b1195fbaf532
relation.isAuthorOfPublication.latestForDiscovery392ba1dd-467b-4d9e-a8f5-b1195fbaf532

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
EvaluationHepatitis_E_Virus_2022.pdf
Size:
640.33 KB
Format:
Adobe Portable Document Format
Description: